Resveratrol

규격

501-36-0CAS 번호

610-504-8EC 번호

5-[(E)-2-(4-hydroxyphenyl)ethenyl]benzene-1,3-diolIUPAC 명칭

C14H12O3화학식

228.24 g/mol분자량

resveratrol; 501-36-0; trans-resveratrol; 3,4',5-Trihydroxystilbene; (E)-resveratrol; Resvida; 3,4',5-Stilbenetriol; 5-[(E)-2-(4-hydroxyphenyl)ethenyl]benzene-1,3-diol; 3,4',5-Trihydroxy-trans-stilbene; 5-[(1E)-2-(4-Hydroxyphenyl)ethenyl]-1,3-benzenediol; Biofort; Cuspidatin; Jotrol; SRT-501; (E)-5-(p-Hydroxystyryl)resorcinol; Resveratrol p 5; SRT501; Melinjo resveratrol 20; DTXSID4031980; Srt 501m; 5-[(E)-2-(4-hydroxyphenyl)vinyl]benzene-1,3-diol; NSC-327430; CHEBI:45713; Ca 1201; BIA 6-512; BIA-6-512; NSC327430; Q369O8926L; 5-((1E)-2-(4-Hydroxyphenyl)ethenyl)-1,3-benzenediol; Cis resveratrol; DTXCID2011980; CHEBI:27881; 5-[(1E)-2-(4-hydroxyphenyl)ethenyl]benzene-1,3-diol; 5-((E)-2-(4-HYDROXYPHENYL)-ETHENYL) BENZENE-1,3 DIOL; 5-((E)-2-(4-hydroxyphenyl)ethenyl)benzene-1,3-diol; 5-((E)-2-(4-hydroxyphenyl)vinyl)benzene-1,3-diol; 5-((1E)-2-(4-hydroxyphenyl)ethenyl)benzene-1,3-diol; 1,3-Benzenediol, 5-((E)-2-(4-hydroxyphenyl)ethenyl)-; 1,3-Benzenediol, 5-[(E)-2-(4-hydroxyphenyl)ethenyl]-; Resveratrol(e)-; (E)-5-(2-(4-hydroxyphenyl)ethenyl)-1,3-benzenediol; Resveratrol 3 sulfate; RefChem:6197; trans Resveratrol 3 O sulfate; Resveratrol NMN Collagen Serum; 610-504-8; trans Resveratrol; (E)-5-(4-Hydroxystyryl)benzene-1,3-diol; 3,5,4'-Trihydroxystilbene; Resveratol; 3,5,4'-Trihydroxy-trans-stilbene; MFCD00133799; trans-3,4',5-trihydroxystilbene; 1,3-Benzenediol, 5-[(1E)-2-(4-hydroxyphenyl)ethenyl]-; Resveratrol(e)-form; Resveratrol (Standard); trans-1,2-(3,4',5-Trihydroxydiphenyl)ethylene; CHEMBL165; (E)-5-[2-(4-hydroxyphenyl)ethenyl]-1,3-benzendiol; MLS000069735; 1,3-Benzenediol, 5-(2-(4-hydroxyphenyl)ethenyl)-, (E)-; trans-3,4',5 - trihydroxystilbene; s1396; SMR000058206; trans-Resveratrol-d4; 5-[2-(4-hydroxyphenyl)vinyl]-1,3-benzenediol; trans-3,4,5-trihydroxystilbene; 3,4',5-trihydroxy-stilbene; SRT 501; SR-01000000163; 5-[(Z)-2-(4-hydroxyphenyl)vinyl]benzene-1,3-diol; 5-[(1E)-2-(4-hydroxyphenyl)vinyl]benzene-1,3-diol; NSC 327430; t-resveratrol; E-resveratrol; CCRIS 8952; Resveratrol CRS; UNII-Q369O8926L; HSDB 7571; 3fts; 4jaz; 4qer; Resveratrol, E-; KUC104385N; Stilbene, 2f; NCGC00015894-02; CAS-501-36-0; STL; Prestwick_619; resveratrol [INN]; Resveratrol (GMP); Resveratrol, trans-; KSC-10-164; RM-1812; Opera_ID_586; RESVERATROL [MI]; Prestwick2_000508; Prestwick3_000508; Spectrum5_000552; RESVERATROL [HSDB]; 3,4',5-Stilbenetriol;; R 5010; RESVERATROL [VANDF]; 1,3-Benzenediol, 5-[(1Z)-2-(4-hydroxyphenyl)ethenyl]-; RESVERATROL [MART.]; RSV-0; Lopac0_001111; REGID_for_CID_6240; SCHEMBL19425; BSPBio_000435; BSPBio_001114; BSPBio_003461; RESVERATROL [WHO-DD]; MLS001055357; MLS001076538; MLS001424228; MLS002207121; MLS002222231; SPECTRUM1502223; CU-01000001503-3; 5-[(E)-2-(4-Hydroxyphenyl)vinyl]-1,3-benzenediol; BPBio1_000479; cid_445154; GTPL8741; orb1308192; orb3139440; SCHEMBL3684840; SGCUT00007; Resveratrol, analytical standard; 3,4',5-trihydrohydroxystilbene; REGID_for_CID_445154; BDBM23926; Resveratrol, >=99% (HPLC); trans-3,5,4'-trihydroxystilbene; 2l98; HMS1362H15; HMS1569F17; HMS1792H15; HMS1921N04; HMS1990H15; HMS2052I09; HMS2096F17; HMS2232A18; HMS3263O04; HMS3403H15; HMS3412O14; HMS3649A20; HMS3676O14; HMS5079L19; HMS6018E16; TRANS-RESVERATROL [USP-RS]; MSK40018; to_000079; Tox21_110257; Tox21_201374; Tox21_303376; Tox21_501111; AC-727; BBL028252; CCG-38874; EBC-11087; HB4055; HY-16561G; HY-16561R; LMPK13090005; SBB055452; STL146386; AKOS005720936; Tox21_110257_1; DB02709; FR09412; KS-5047; LP01111; NC00349; SDCCGMLS-0002998.P003; SDCCGSBI-0051080.P003; IDI1_002152; NCGC00017352-05; NCGC00017352-06; NCGC00017352-07; NCGC00017352-08; NCGC00017352-09; NCGC00017352-10; NCGC00017352-11; NCGC00017352-12; NCGC00017352-13; NCGC00017352-14; NCGC00017352-15; NCGC00017352-16; NCGC00017352-17; NCGC00017352-18; NCGC00017352-19; NCGC00017352-24; NCGC00017352-31; NCGC00017352-37; NCGC00017352-39; NCGC00024003-00; NCGC00024003-04; NCGC00024003-05; NCGC00024003-06; NCGC00024003-07; NCGC00024003-08; NCGC00024003-09; NCGC00024003-10; NCGC00024003-11; NCGC00024003-12; NCGC00024003-13; NCGC00024003-14; NCGC00257465-01; NCGC00258925-01; NCGC00261796-01; AS-12413; HY-16561; ST057251; SY014849; CS-0694771; EU-0101111; R0071; R1776; Resveratrol, Vetec(TM) reagent grade, 98%; SW196786-4; trans [2,5,4'-trihydroxydiphenyl] ethylene; trans-Resveratrol 100 |Ig/mL in Acetonitrile; C03582; M02442; N88795; AB00052942-29; AB00052942_31; trans-Resveratrol 100 microg/mL in Acetonitrile; AE-641/30608044; Q407329; 5-[(E)-2-(4-Hydroxyphenyl)vinyl]-1,3-benzoldiol; SR-01000000163-3; SR-01000000163-4; SR-01000000163-9; 5-[(E)-2-(4-Hydroxyphenyl)ethenyl]benzol-1,3-diol; 5[(E)-2-(4-Hydroxyphenyl)-vinyl]benzene 1,3-diol; BRD-K25591257-001-01-2; BRD-K80738081-001-06-2; BRD-K80738081-001-07-0; BRD-K80738081-001-09-6; BRD-K80738081-001-10-4; BRD-K80738081-001-23-7; BRD-K80738081-001-42-7; BRD-K80738081-001-43-5; BRD-K80738081-001-44-3; BRD-K80738081-001-46-8; SR-01000000163-10; SR-01000000163-11; SR-01000000163-16; (E)-1-(3,5-dihydroxyphenyl)-2-(4-hydroxyphenyl)ethene; (E)1-(3,5-dihydroxyphenyl)-2-(4-hydroxyphenyl)ethene; 5-[(e)-2-(4-hydroxyphenyl)-ethenyl]benzene-1,3-diol; Resveratrol, certified reference material, TraceCERT(R); 5-[(E)-2-(4-Hydroxyphenyl)ethen-1-yl]benzene-1,3-diol; Resveratrol, European Pharmacopoeia (EP) Reference Standard; 533C1DA0-4104-42B5-9D32-9265F40857E4; trans-Resveratrol, United States Pharmacopeia (USP) Reference Standard; (E)-5-(2-(4-hydroxyphenyl)ethenyl)-1,3-benzenediol(E)-5-(2-(4-hydroxyphenyl)ethenyl)-1,3-benzenediol; 31100-06-8; InChI=1/C14H12O3/c15-12-5-3-10(4-6-12)1-2-11-7-13(16)9-14(17)8-11/h1-9,15-17H/b2-1동의어